These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34638207)

  • 1. [Nodular regenerative hyperplasia of liver caused by chemotherapy: magnetic resonance imaging features].
    Huang Z; Wang ML; Ji Y; Luo RK; Rao SX; Zeng MS
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):873-877. PubMed ID: 34638207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of MRI features of hepatocyte nuclear factor 1α-inactivated hepatocellular adenoma].
    Pan H; Chen XF; Han J; Ji Y; Zeng MS; Wang ML
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1192-1197. PubMed ID: 38238954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Magnetic resonance imaging and diffusion weighted imaging features of focal peliosis hepatis].
    Liu ZJ; Yao JM; Wang ML; Geng TT; Dong G; Zeng MS
    Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(7):496-499. PubMed ID: 30786345
    [No Abstract]   [Full Text] [Related]  

  • 4. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
    Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
    Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic pseudolymphoma: imaging features on dynamic contrast-enhanced MRI and diffusion-weighted imaging.
    Zhou Y; Wang X; Xu C; Zhou G; Zeng M; Xu P
    Abdom Radiol (NY); 2018 Sep; 43(9):2288-2294. PubMed ID: 29392361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
    PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd-EOB-DTPA Enhanced MRI Features of Liver Hemangiomatosis Coexistent with GCH.
    Liu D; Qiao Z; Xu L; Fu F; Ye A; Hu C
    Curr Med Imaging; 2022; 18(13):1390-1395. PubMed ID: 35657047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.
    Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
    Medicine (Baltimore); 2017 Jul; 96(29):e7278. PubMed ID: 28723741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.
    Haimerl M; Wächtler M; Zeman F; Verloh N; Platzek I; Schreyer AG; Stroszczynski C; Wiggermann P
    PLoS One; 2014; 9(6):e100315. PubMed ID: 24950259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS
    J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
    Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
    Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
    Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
    Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application value of Gd-EOB-DTPA enhanced MRI based radiomics in the differential diagnosis of iso-or hyperintensity HCC and focal nodular hyperplasia in hepatobiliary phase].
    Mao HY; Yu YX; Zhang JY; Zhang T; Fan YF; Hu S; Wang XM; Hu CH
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(33):2599-2606. PubMed ID: 37650206
    [No Abstract]   [Full Text] [Related]  

  • 15. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
    Kim SS; Kim SH; Song KD; Choi SY; Heo NH
    J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease.
    Kim HS; Kim SH; Kang TW; Song KD; Choi D; Park CK
    Eur J Radiol; 2015 Apr; 84(4):555-62. PubMed ID: 25617950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
    Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM
    J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.